sequencing and prediction of adolescent soft drug …literature; 2) test a modified version of...
TRANSCRIPT
Sequencing and Prediction of Adolescent Soft Drug Initiation:
Systematic Review, Quantitative Investigation, and Dual Cross-Validation
Rebecca J. Howell
DISSERTATION.COM
Boca Raton
Sequencing and Prediction of Adolescent Soft Drug Initiation:
Systematic Review, Quantitative Investigation, and Dual Cross-Validation
Copyright © 2008 Rebecca J. Howell All rights reserved. No part of this book may be reproduced or transmitted in any form or by any
means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without written permission from the publisher.
Dissertation.com
Boca Raton, Florida USA • 2010
ISBN-10: 1-59942-332-4
ISBN-13: 978-1-59942-332-6
iv
Title: Sequencing and Prediction of Adolescent Soft Drug Initiation: Systematic Review, Quantitative Investigation, and Dual Cross-Validation
Author: Rebecca J. Howell Dissertation Chair: Dr. David L. Myers Dissertation Committee Members: Dr. Dennis M. Giever Dr. Jamie Martin Dr. Jennifer Roberts
In providing a comprehensive investigation of alcohol, cigarette, and
marijuana initiation among adolescents, the overarching goals of the research
were to build upon extant findings, address important gaps found in the literature,
and contribute to the prevention science knowledge base. A four-fold purpose
founded the study: 1) provide a systematic review of the soft drug initiation
literature; 2) test a modified version of Kandel’s (2002) drug sequencing
hypothesis; 3) determine if predictors of soft drug initiation differ in kind or
saliency by biological age and drug type; and 4) examine age- and drug- specific
determinants of the timing at which soft drug initiation occurs. Supplemental
attention also was directed at evaluating the utility of Petraitis et al.’s (1995)
distal-proximal mediation hypothesis.
Through the quantitative component of the research, nine hypotheses
were tested. Cross-sectional data were derived from a rural sample of 6th, 9th,
and 12th grade students who completed the 2004 Primary Prevention Awareness,
Attitude, and Use Survey (PPAAUS). All of the hypotheses obtained some
degree of support; more support was yielded for the specific risk factor
hypothesis than the common factor model, and convincing evidence was
v
obtained for Kandel’s drug sequencing hypothesis and Petraitis et al.’s distal-
proximal mediation hypothesis.
The findings also supported the bulk of the directional hypotheses and
several of the direct and indirect effects propositions put forth in social learning
theory, the social development model, and the theory of planned behavior. In
contrast, the results called into question some of the direct effects articulated in
Hirschi’s original statement of social control and underscored some possible
limits of the social development model.
In an effort to gauge the validity of the findings, a dual cross-validation
scheme was employed. The systematic review cross-validation involved
comparing the quantitative findings for two major hypotheses to those yielded
from 36 primary studies examined in the systematic review. Through a further
quantitative cross-validation, the findings for the major and supplemental
hypotheses were compared to those derived from a sample of 6th, 9th and 12th
grade students who completed the 2001 PPAAUS. On balance, a relatively
strong degree of convergence was obtained. This confluence served to bolster
the reliability and validity of the results. Policy and programmatic implications
also were indicated.
vi
ACKNOWLEDGMENTS
First, and foremost, I want to thank and give credit to God for all of my
accomplishments, academic or otherwise. Ultimately, it’s due to His strength,
love, and care that I’m able to see my doctoral work to completion.
I’d also like to acknowledge my best friend, lifeline, and husband, David,
for supporting my goals and passion. Thank you for reminding me to “stop and
smell the roses.” Your selflessness and loyalty do not go unnoticed.
Much of the research I’ve had the opportunity to be involved with,
including the PPAAUS, is the direct result of Dave Myers’ generosity and
instrumental guidance. Dave, I’m extremely grateful for your mentorship, the
research opportunities that you provided, and the wisdom you departed along the
way. Not only were you the best dissertation chair one could wish for, but you
continue to be an inspirational role model. I have yet to meet an academic as
grounded, patient, and laid-back, yet professional and hard-core.
The suggestions and points of clarity that my committee members, Jamie,
Jen, and Dennis, provided were both instructive and helpful in solidifying this
research. Thank you all for your time, effort, and constructive feedback
throughout the process.
Michelle Corcoran and Joyce Kensey from the IUP library were invaluable
throughout the literature collection stages of this study. I appreciate your
diligence in processing my ILL requests in a more than timely manner.
Finally, to the IUP criminology faculty-- thank you for the thorough training.
I enjoyed the experience, learned a ton, and hope to “pay it forward.”
vii
For Lucas, Mazzy, Katie, and all other like children.
viii
TABLE OF CONTENTS Chapter Page 1 INTRODUCTION ................................................................................ 1 A Cultural Mainstay ............................................................................ 2 A Social and Public Health Problem ................................................... 6 Utility of Prevention and Research ................................................... 17 Purpose of the Research ................................................................. 24 2 TRADITIONAL ETIOLOGY .............................................................. 30 Social Control Theory ....................................................................... 31 Differential Association Theory ......................................................... 42 Social Learning Theory .................................................................... 44 Conclusion ....................................................................................... 60 3 DEVELOPMENTAL ETIOLOGY ...................................................... 69 The Developmental Approach .......................................................... 70 Stage Theory ................................................................................... 75 Social Development Model .............................................................. 97 Conclusion ..................................................................................... 126 4 SEQUENCING AND PREDICTION RESEARCH ........................... 131 Sequencing Research .................................................................... 131 Prediction Research ....................................................................... 158 Conclusion ..................................................................................... 186 5 SYSTEMATIC REVIEW METHODS .............................................. 192 Nature of Comprehensive Literature Reviews ................................ 193 Quality and Focus of Extant Reviews ............................................. 199 Systematic Review Methodology ................................................... 209 Systematic Review Analysis Plan .................................................. 220 Systematic Review Cross-Validation .............................................. 225 Conclusion ..................................................................................... 239 6 QUANTITATIVE METHODS .......................................................... 241 Secondary Data Source and Sample Attributes ............................. 241 Research Questions and Hypotheses ............................................ 248 Dependent Variables ...................................................................... 261 Independent and Control Variables ................................................ 263
ix
Chapter Page Analytic Techniques ....................................................................... 272 Model Development and Logistics ................................................. 293 Quantitative Cross-Validation ......................................................... 303 7 SYSTEMATIC REVIEW RESULTS ................................................ 322 Summary Description of the Primary Studies ................................. 323 Soft Drug Initiation .......................................................................... 331 Time to Soft Drug Initiation ............................................................. 373 Overview of Key Findings and Attendant Gaps .............................. 378 8 UNIVARIATE AND BIVARIATE RESULTS .................................... 396 Sample Descriptives ...................................................................... 396 Bivariate Correlations ..................................................................... 403 Research Question #1 ................................................................... 423 Conclusion ..................................................................................... 434 9 MULTIVARIATE RESULTS............................................................ 435 Research Question #2 ................................................................... 435 Research Question #3 ................................................................... 461 Drug- and Age-Specific Predictors ................................................. 513 Hypotheses Results ....................................................................... 528 Conclusion ..................................................................................... 548 10 DUAL CROSS-VALIDATION RESULTS ........................................ 550 Systematic Review Cross-Validation .............................................. 550 Quantitative Cross-Validation ......................................................... 570 Validity of the 2004 PPAAUS Results ............................................ 592 Conclusion ..................................................................................... 623 11 DISCUSSION AND CONCLUSIONS ............................................. 626 General Contributions of the Research .......................................... 628 Theoretical and Empirical Implications ........................................... 634 Policy and Programmatic Implications ........................................... 669 Study Limits.................................................................................... 678 Recommendations for Further Research ....................................... 682 Conclusion ..................................................................................... 691 REFERENCES ............................................................................................ 693
x
Chapter Page APPENDICES ............................................................................................. 784 A: 2004 PPAAUS Instrument ................................................................. 784 B: 2004 PPAAUS Administration Instructions and Teacher Script ......... 785 C: Independent and Control Variables: Coding Schemes ...................... 786 D: Detailed Account of Guttman Scale Development ............................. 795 E: 2001 PPAAUS Instrument ................................................................. 801 F: Primary Studies for Systematic Review ............................................. 802 G: 2001 PPAAUS Univariate, Bivariate, and Multivariate Results .......... 838
xi
LIST OF TABLES
Table Page
1 Prominent Integrated Developmental Theories of Adolescent Drug Use ............................................................................................. 71 2 Empirical Tests of Kandel’s Drug Sequencing Hypothesis ............... 133 3 Historical Time Periods in which Drug Sequencing
Data were Drawn .............................................................................. 138 4 Empirical Support using Guttman Scaling: Coefficients
of Reproducibility and Scalability ...................................................... 144
5 Community Domain Risk Factors and Empirical Support ................. 159
6 School Domain Risk Factors and Empirical Support ........................ 161
7 Family Domain Risk Factors and Empirical Support ......................... 162
8 Peer Domain Risk Factors and Empirical Support ............................ 165
9 Individual Domain Risk Factors and Empirical Support .................... 166
10 Major Calls for Future Research ....................................................... 174
11 Drawbacks of Extant Comprehensive Literature Reviews ................ 201
12 Inclusion Criteria for Systematic Review ........................................... 211
13 Electronic Databases and Organization/Agency Internet Websites Searched ........................................................................... 218
14 Prediction Models Eligible for Systematic Review, by Drug Type .................................................................................... 219 15 Primary Studies for Systematic Review ............................................ 219
16 Major Study Characteristics with Examples ...................................... 221
17 Ecological Domains and Related Predictor Categories .................... 223
18 Overview of Research Questions, Attendant Hypotheses, and Analytic Techniques .................................................................. 249
xii
Table Page 19 Prediction Analyses: Community Domain Predictors, Theoretical/Empirical Grounding ....................................................... 264 20 Prediction Analyses: School Domain Predictors, Theoretical/Empirical Grounding ....................................................... 266
21 Prediction Analyses: Family Domain Predictors, Theoretical/Empirical Grounding ....................................................... 267
22 Prediction Analyses: Peer Domain Predictors, Theoretical/Empirical Grounding ....................................................... 268 23 Prediction Analyses: Individual Domain Predictors, Theoretical/Empirical Grounding ....................................................... 269 24 Prediction Analyses: Control Variables and
Theoretical Constructs ...................................................................... 271
25 Example of Guttman Response Matrix that Incorporates Age of Initiation ................................................................................. 279 26 Example of Error-Counting for Supplemental Analysis ..................... 281 27 Primary Studies, Basic Descriptives ................................................. 323 28 Community Domain Predictors of Soft Drug Initiation: Directional Relationships by Period of Adolescent Development ...... 332 29 School Domain Predictors of Soft Drug Initiation: Directional Relationships by Period of Adolescent Development ...... 337 30 Family Domain Predictors of Soft Drug Initiation: Directional Relationships by Period of Adolescent Development ...... 341 31 Peer Domain Predictors of Soft Drug Initiation: Directional Relationships by Period of Adolescent Development ...... 353 32 Individual Domain Predictors of Soft Drug Initiation:
Directional Relationships by Period of Adolescent Development ...... 361 33 Family Domain Predictors of Time to Soft Drug Initiation: Directional Relationships, Early-Late Adolescence ........................... 375
xiii
Table Page 34 Peer Domain Predictors of Time to Soft Drug Initiation: Directional Relationships, Early-Late Adolescence ........................... 376
35 Individual Domain Predictors of Time to Soft Drug Initiation: Directional Relationships, Early-Late Adolescence ........................... 377
36 Primary Studies: Select Design, Domain, and
Predictor Descriptives by Outcome and Sample Population ............. 380 37 Soft Drug Initiation: Most and Least Researched Stages of Adolescent Development by Ecological Domain............... 383
38 Dependent Measures: Descriptives for Total Sample ....................... 397 39 Dichotomous Predictors/Controls: Percentage
Frequencies (N = 753) .......................................................................398
40 Ordinal/Continuous Predictors and Controls: Descriptives (N = 753) ...................................................................... 399
41 Dichotomous Initiation: Bivariate Correlations .................................. 405
42 Age of Initiation: Bivariate Correlations ............................................. 414
43 Predictors and Controls: Bivariate Correlations ± .400
or Greater (N = 753) ......................................................................... 419
44 Temporal Ordering in Soft Drug Sequences ..................................... 425
45 Dichotomous Initiation and Time to Initiation Models (Total Sample): Predictor Listing ....................................................... 436
46 Model #1: Predictors of Alcohol Initiation, Total Sample ................... 439
47 Model #2: Predictors of Cigarette Initiation, Total Sample ................ 441
48 Model #3: Predictors of Marijuana Initiation, Total Sample ............... 443 49 Model #4: Predictors of Time to Alcohol Initiation, Total Sample ...... 451
50 Model #5: Predictors of Time to Cigarette Initiation, Total Sample ... 452
51 Model #6: Predictors of Time to Marijuana Initiation, Total Sample .. 454
xiv
Table Page
52 Dependent Measures: Descriptives for Age-Graded Subsamples .... 464 53 Model #7: Predictors of Alcohol Initiation among
6th Grade Students ............................................................................ 466 54 Model #8: Predictors of Alcohol Initiation among
9th Grade Students ............................................................................ 468 55 Model #9: Predictors of Alcohol Initiation among
12th Grade Students .......................................................................... 470 56 Model #10: Predictors of Cigarette Initiation among
6th Grade Students ............................................................................ 474 57 Model #11: Predictors of Cigarette Initiation among
9th Grade Students ............................................................................ 475 58 Model #12: Predictors of Cigarette Initiation among
12th Grade Students .......................................................................... 477 59 Model #13: Predictors of Marijuana Initiation among
9th Grade Students ............................................................................ 482 60 Model #14: Predictors of Marijuana Initiation among
12th Grade Students .......................................................................... 484 61 Model #15: Predictors of Time to Alcohol Initiation among
6th Grade Students ............................................................................ 489 62 Model #16: Predictors of Time to Alcohol Initiation among
9th Grade Students ............................................................................ 491 63 Model #17: Predictors of Time to Alcohol Initiation among
12th Grade Students .......................................................................... 493 64 Model #18: Predictors of Time to Cigarette Initiation among
6th Grade Students ............................................................................ 498 65 Model #19: Predictors of Time to Cigarette Initiation among
9th Grade Students ............................................................................ 500 66 Model #20: Predictors of Time to Cigarette Initiation among
12th Grade Students .......................................................................... 501
xv
Table Page 67 Model #21: Predictors of Time to Marijuana Initiation among
9th Grade Students ............................................................................ 507 68 Model #22: Predictors of Time to Marijuana Initiation among
12th Grade Students .......................................................................... 509 69 Total Sample and Age-Graded Results: Drug and Age-Specific
Predictors (p <.05 or lower)............................................................... 516 70 Total Sample and Age-Graded Findings: Possible
Age X Factor Interaction Effects ....................................................... 527
71 Hypothesis 7 Findings, 2004 PPAAUS: Percentage Decrease in Final Model R2/ 2 Attributed to the Community Domain ................ 539
72 Hypothesis 8 Findings, 2004 PPAAUS: Direct Effect of Parental Pro-Drug Norms on Respective Outcomes ........................ 542
73 Hypothesis 9 Findings, 2004 PPAAUS: Direct Effects of Peer Soft Drug Use and Pro-Drug Norms on Respective Outcomes ........ 544
74 Proportion of Extraneous Effects as Indirect, 2004 PPAAUS: Total Sample and Age-Graded Models ............................................. 547
75 Systematic Review Cross-Validation Findings: H2 Results for Soft Drug Initiation among the Total Sample .................................... 553
76 Systematic Review Cross-Validation Findings: H2 Results for Soft Drug Initiation among Early, Mid-, and Late Adolescents .......... 555
77 Systematic Review Cross-Validation Findings: H2 Results for Time to Soft Drug Initiation among the Total Sample ....................... 562
78 Systematic Review Cross-Validation Findings: H3 Results for
Soft Drug Initiation among the Total Sample .................................... 564 79 Systematic Review Cross-Validation Findings: H3 Results for
Soft Drug Initiation among Early, Mid-, and Late Adolescents .......... 567 80 Differential Model Fit: 2004 and 2001 PPAAUS ................................ 573 81 2004 and 2001 PPAAUS: H2 Counter Findings ................................ 577
82 2004 and 2001 PPAAUS: H3 Counter Findings ................................ 578
xvi
Table Page 83 Hypothesis 7 Findings, 2001 PPAAUS: Percentage Decrease
in Final Model R2/ 2 Attributed to the Community Domain ................ 585 84 Hypothesis 9 Findings, 2001 PPAAUS: Direct Effects of Peer
Soft Drug Use and Pro-Drug Norms on Respective Outcomes ........ 588 85 Proportion of Extraneous Effects as Indirect, 2001 PPAAUS:
Total Sample and Age-Graded Models ............................................. 590
86 Triangulation of the H2 and H3 Counter Findings from the Systematic Review Cross-Validation ................................................ 595
87 Possible Explanations for Conflicting Findings: Major Differences
between the 2004 PPAAUS and Relevant Primary Studies.............. 596 88 Major Research Gaps Identified through the Systematic Review ..... 688
xvii
LIST OF APPENDICED TABLES
Appendix/Table Page
C1 Block #1: Community Domain Predictors.......................................... 786 C2 Block #2: School Domain Predictors ................................................. 787 C3 Block #3: Family Domain Predictors ................................................. 789 C4 Block #4: Peer Domain Predictors .................................................... 790 C5 Block #5: Individual Domain Predictors............................................. 791 C6 Block #6: Control Variables ............................................................... 794
G1 2001 PPAAUS, Dependent Measures: Descriptives for Total Sample ..................................................................................... 838 G2 2001 PPAAUS, Dependent Measures: Descriptives for Age-Graded Subsamples .................................................................. 838 G3 2001 PPAAUS, Dichotomous Predictors/Controls: Percentage Frequencies (N = 723) ...................................................................... 839
G4 2001 PPAAUS, Ordinal/Continuous Predictors and Controls: Descriptives (N = 723) ...................................................................... 841
G5 2001 PPAAUS, Bivariate Correlations, Dichotomous Initiation ......... 843
G6 2001 PPAAUS, Bivariate Correlations, Age of Initiation.................... 845
G7 2001 PPAAUS, Predictors and Control Variables: Bivariate Correlations ± .400 (N = 723) ............................................................ 847 G8 2001 PPAAUS, Predictors of Alcohol Initiation, Total Sample .......... 850
G9 2001 PPAAUS, Predictors of Cigarette Initiation, Total Sample ....... 852 G10 2001 PPAAUS, Predictors of Marijuana Initiation, Total Sample ...... 854 G11 2001 PPAAUS, Predictors of Time to Alcohol Initiation, Total Sample ..................................................................................... 856 G12 2001 PPAAUS, Predictors of Time to Cigarette Initiation, Total Sample ..................................................................................... 858
xviii
Appendix/Table Page
G13 2001 PPAAUS, Predictors of Time to Marijuana Initiation, Total Sample ..................................................................................... 860 G14 2001 PPAAUS, Predictors of Alcohol Initiation among 6th Grade Students ............................................................................ 863
G15 2001 PPAAUS, Predictors of Alcohol Initiation among 9th Grade Students ............................................................................ 864
G16 2001 PPAAUS, Predictors of Alcohol Initiation among 12th Grade Students .......................................................................... 866
G17 2001 PPAAUS, Predictors of Cigarette Initiation among 6th Grade Students ............................................................................ 867
G18 2001 PPAAUS, Predictors of Cigarette Initiation among 9th Grade Students ............................................................................ 868
G19 2001 PPAAUS, Predictors of Cigarette Initiation among 12th Grade Students .......................................................................... 870
G20 2001 PPAAUS, Predictors of Marijuana Initiation among 9th Grade Students ............................................................................ 871 G21 2001 PPAAUS, Predictors of Marijuana Initiation among 12th Grade Students .......................................................................... 873
G22 2001 PPAAUS, Predictors of Time to Alcohol Initiation among 6th Grade Students ............................................................................ 875
G23 2001 PPAAUS, Predictors of Time to Alcohol Initiation among 9th Grade Students ............................................................................ 876
G24 2001 PPAAUS, Predictors of Time to Alcohol Initiation among 12th Grade Students .......................................................................... 877
G25 2001 PPAAUS, Predictors of Time to Cigarette Initiation among 6th Grade Students ............................................................................ 879
G26 2001 PPAAUS, Predictors of Time to Cigarette Initiation among 9th Grade Students ............................................................................ 880 G27 2001 PPAAUS, Predictors of Time to Cigarette Initiation among 12th Grade Students .......................................................................... 882
xix
Appendix/Table Page
G28 2001 PPAAUS, Predictors of Time to Marijuana Initiation among 9th Grade Students ............................................................................ 883 G29 2001 PPAAUS, Predictors of Time to Marijuana Initiation among 12th Grade Students .......................................................................... 884
xx
LIST OF FIGURES
Figure Page
1 Hobbes gives Calvin some sound advice, by Bill Watterman, 1994.
© 1990 Universal Press Syndicate. Reprint permission granted
through education provision ................................................................ 20
2 This transition diagram depicts H1, the most common soft drug
initiation sequence found in the data (n = 713) ................................. 427
3 This transition diagram depicts cigarettes>alcohol>marijuana, the
second most common soft drug initiation sequence (n = 713) .......... 429
1
CHAPTER 1
INTRODUCTION
In the grocery store, a 5-year-old boy selected wine and asked, “Is this alcohol?” The researcher replied, “Yes,” and the boy said, “I want it, and I want some smokes.”
At the check-out counter, a 3-year-old girl identified the cigarettes she was buying. Camels: “Animal ones for Daddy.” Marlboros: “Mommy smokes these.”
(Dalton et al., 2005)
Quite perceptive, some children as young as age 3 already have begun to
develop an awareness of (and cognitive expectation for) alcohol and cigarette
use. In a recent adult role-playing study (Dalton et al., 2005), substantial
percentages of preschoolers (2 to 6 years of age) purchased cigarettes (29%)
and alcohol (62%) at a toy grocery store in preparation for a make-believe
evening with friends. Disconcerting are the findings that about half of these
children correctly identified alcohol (58%) and cigarettes (50%) by brand name,
with some children more adept at identifying the names of these products than
the names of those that are more age-appropriate, such as snacks and cereal.
Dalton et al.’s (2005) findings not only speak to the ability that young children
have for internalizing and emulating general social cues to which they have been
exposed; these researchers also found that compared to children whose parents
self-reported cigarette and alcohol abstinence, children whose parents drank on
a monthly basis or smoked were 3 and 4 times more likely, respectively, to
purchase alcohol and cigarette products.
Given the multiple cultural forces (e.g., media, pharmaceutical
corporations, and the alcohol, tobacco, and music industries) that glamorize,
celebrate, and encourage drug use, along with the prevalence of soft drug use
2
among adults and the emerging finding that parents constitute the #1 source of
alcohol for a considerable number of adolescents (American Medical Association
[AMA], 2005), it is not surprising that young children are developing a keen
awareness of the central role that these drugs play in the lives of many parents
and adults (see, e.g., Cieply, 2007; Dombrink, 1993; Grube, 2004; Jurgensen,
2007; Strasburger, 1995; Wakefield, Flay, Nichter, & Giovino, 2003; Watson,
2005). Although troubling, it also is hardly a surprise that national and statewide
epidemiologic drug surveys conducted over the past 15 years suggest as many
as 10% of typical 4th graders in the U.S. already have initiated alcohol use
(Donovan, 2007). In an effort to understand why cognitive expectations
concerning soft drug use may develop in American children by 5 years of age, it
is important to place the issue of soft drug use within a historical context.
A Cultural Mainstay
To begin, as the oldest known psychoactive drug in the U.S. and the
world, alcohol has been firmly embedded in American culture since its first
migration aboard Puritan ships (Inaba & Cohen, 2004). Today, alcohol remains a
focal point of American life, from its incorporation into holiday traditions and
religious ceremonies, to social gatherings, weekday happy hours, and weekend
parties.
The current legal drinking age in the U.S., 21 years, is the highest of any
country in the world (Babor et al., 2003). The prohibition of alcohol to minors first
began in the mid 1800s with the enactment of various state laws. The push for
establishing these laws originated from various puritanical temperance groups in
3
the early 1800s, whose interest was to restrict both adult and youth access to
alcohol (Alcohol and Tobacco Tax and Trade Bureau, 2006). Major subsequent
curtailments of legal access to alcohol included the enactment of the 1920
National Prohibition Act and the passage of the 18th Amendment to the U.S.
Constitution. After state ratification, the federal government repealed Prohibition
in 1933 with the passage of the 21st Amendment. Although the federal ban
against the manufacturing, transportation, and sale of alcohol was lifted,
prohibition laws remained intact in many states. States without these laws
allowed for the sale of alcohol to adults, while restricting the sale of alcohol to
anyone under the age of 21 years.
After the 26th Amendment was enacted in 1971, and those between the
ages of 18 and 21 years were afforded the right to vote, states began lowering
minimum drinking ages from 21 years to 20, 19, and 18 years (Inaba & Cohen,
2004). Influenced by federal coercion, states then reversed their legal drinking
ages in the 1980s, increasing them back to 21 years (Humfleet, Munoz, Sees,
Reus, & Hall, 1999). Decisions to increase the legal drinking age were founded
on concerns about the impact of alcohol consumption on youth psychosocial
development, along with the strong correlation found between lowered drinking
ages and motor vehicle accidents and fatalities (Cook & Tauchen, 1984).
In comparison to alcohol, tobacco use in the U.S. began as early as 1
B.C., when American Indians utilized tobacco leaves in religious rituals and
medicinal practice (Borio, 2005). Since 1847, when the first cigarette was sold in
the U.S. by a newly founded British company, Phillip Morris, cigarette production
4
and sales have evolved into one of the most profitable businesses ever
established in the U.S. (Randall, 2006).
First influenced by the 1964 U.S. Surgeon General’s report on the
negative health consequences of cigarette smoking, restrictions on cigarette
advertising and use have become increasingly stringent in modern times. Today,
all tobacco advertising on television and radio is banned; smoking is prohibited
on all commercial airline flights; many states restrict smoking in public
establishments; and tobacco companies also are mandated to inform the public
of the health dangers associated with smoking (Randall, 2006). Although there is
no federal law mandating that tobacco products only be sold to persons of a
specified minimum age, coercive encouragement by the federal government has
aided in the passage of legislation in all 50 states requiring the sale of tobacco
products only to persons over the age of 18 (Inaba & Cohen, 2004).
Finally, mankind has been using marijuana for at least 4,000 years
(Abadinsky, 2001). Not only has it been used for its euphoric properties and
ability to produce a “high,” but also for its medicinal properties in countries such
as China and India, and in areas of South America, the Middle East, and
southern Africa (Abadinsky, 2001). In the U.S., marijuana first was grown and
used as a source of fiber during Colonial Times. Over time, Americans began
utilizing it to treat various health conditions and illnesses, such as rheumatism
and labor pains during childbirth (Joy, Watson, & Benson, 1999).
The criminalization of marijuana has been a cornerstone of federal drug
policy, starting with the 1914 Harrison Narcotics Act (Gray, 2001). Through the
5
passage of the Controlled Substances Act (CSA), a subsidiary Act of the
Comprehensive Drug Abuse Prevention and Control Act (CDAPCA) of 1970,
marijuana was deemed a Schedule I substance (Drug Enforcement Agency
[DEA], 2006). In general, Schedule I drugs are viewed as having no medicinal
value and being dangerous in terms of the potential for abuse and dependence
(DEA, 2006).
In an effort to centralize federal drug enforcement under one agency, the
DEA was established in 1973 (Abadinsky, 2001). Since its inception, the DEA
has been responsible for the federal enforcement of drug laws and interdiction
efforts. The “war on drugs,” which initially began in the 1970s at the direction of
President Nixon, was employed in full force from the 1980s, under the Reagan
administration, through at least the early 1990s, under the Bush administration.
This “war on drugs” and the associated “zero tolerance” approach were geared
toward all illicit substances, including marijuana. During this time, mandatory
sentences for drug possession were re-introduced, and drug enforcement and
interdiction initiatives increased, as did arrests for drug offenses, including
marijuana possession (Abadinsky, 2001; Inaba & Cohen, 2004).
Although the “war on drugs” still continues in various capacities today,
increasing tolerance of marijuana use has led to amplified public support for its
legalization. Although its use remains a federal crime, 13 states have passed one
or more medical marijuana laws or have provided for exceptions to existing state
laws (Gray, 2001; Pacula, Chriqui, & King, 2004). Several cities also have